Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
The protein tyrosine phosphatase CD45 promotes PMN transepithelial migration, antimicrobial function, and colonic mucosal repair
Jael Miranda, Dylan J. Fink, Zachary S. Wilson, Roland Hilgarth, Asma Nusrat, Charles A. Parkos, Jennifer C. Brazil
Jael Miranda, Dylan J. Fink, Zachary S. Wilson, Roland Hilgarth, Asma Nusrat, Charles A. Parkos, Jennifer C. Brazil
View: Text | PDF
Research Article Immunology Inflammation

The protein tyrosine phosphatase CD45 promotes PMN transepithelial migration, antimicrobial function, and colonic mucosal repair

  • Text
  • PDF
Abstract

Polymorphonuclear neutrophils (PMNs) serve as frontline defenders against injury and infection, eliminating pathogens and initiating mucosal tissue repair. However, excessive PMN transepithelial migration (TEpM) contributes to chronic mucosal inflammatory disorders, including inflammatory bowel disease. PMN proinflammatory and pro-repair functions are regulated by incompletely defined signaling cascades involving kinases and phosphatases. Here, we determined how the protein tyrosine phosphatase CD45/PTPRC regulates PMN trafficking and effector functions in the gut. Pharmacologic inhibition of CD45 significantly reduced PMN colonic TEpM in vitro and in vivo and decreased intestinal PMN trafficking was observed in transgenic mice with PMN-specific deletion of Cd45 (MRP8-Cre;Cd45fl/fl). Beyond limiting TEpM, CD45 depletion impaired key antimicrobial functions, including degranulation and phagocytosis, indicating broader effects on PMN effector activity. Importantly, recovery from dextran sodium sulfate–induced colitis and biopsy-induced colonic wounding was delayed in MRP8-Cre;Cd45fl/fl mice, linking altered PMN function to defective mucosal healing. Mechanistically, CD45 depletion reduced surface expression of the β2 integrin CD11b/CD18 and inactivated the Src family kinase member Lyn. Together, these data highlight an important CD45/CD11b/Lyn signaling axis that regulates PMN trafficking and effector functions in the intestine and identify CD45 as a promising target for modulating PMN function to promote mucosal tissue repair.

Authors

Jael Miranda, Dylan J. Fink, Zachary S. Wilson, Roland Hilgarth, Asma Nusrat, Charles A. Parkos, Jennifer C. Brazil

×

Figure 5

Generation of PMN-specific CD45-deficient mice.

Options: View larger image (or click on image) Download as PowerPoint
Generation of PMN-specific CD45-deficient mice.
(A) PCR revealed a 90% r...
(A) PCR revealed a 90% reduction in Cd45 expression in PMNs from MRP8-Cre;Cd45fl/fl mice compared with Cd45fl/fl PMNs (n = 3 independent experiments). (B) Representative immunoblot showing CD45 expression in MRP8-Cre;Cd45fl/fl versus Cd45fl/fl PMNs. Data represent PMNs isolated from 3 mice per genotype. (C) Densitometry revealed a 90% reduction in CD45 expression in MRP8-Cre;Cd45fl/fl PMNs relative to Cd45fl/fl PMNs. Data represent mean band intensity normalized to GAPDH relative to Cd45fl/fl (n = 3 independent experiments). (D) Gating strategy for bone marrow immune cells showing CD11b+Siglec-F–Ly6G+Ly6C+ cells (PMNs) and CD11b+Siglec-F–Ly6G–Ly6C+ cells (monocytes). (E and F) Flow cytometric analysis of Ly6G+Ly6C+ PMNs shows a 90% reduction in CD45 surface expression in bone marrow MRP8-Cre;Cd45fl/fl PMNs compared with Cd45fl/fl PMNs. Data represent mean fluorescence intensity (MFI) (n = 3 independent experiments). (G and H) Flow cytometric analysis of CD45 surface expression in bone marrow monocytes (Ly6G–Ly6C+) from MRP8-Cre;Cd45fl/fl mice compared with Cd45fl/fl control mice. Data represent MFI (n = 3 independent experiments). (I) Gating strategy for circulating immune cells showing CD11b+Siglec-F–Ly6G+Ly6C+ cells (PMNs) and CD11b+Siglec-F–Ly6G–Ly6C+ cells (monocytes). (J and K) Flow cytometric analysis of Ly6G+Ly6C+ PMNs shows a 90% reduction in CD45 surface expression in circulating PMNs (Ly6G+Ly6C+) from MRP8-Cre;Cd45fl/fl mice compared with Cd45fl/fl control mice. Data represent MFI (n = 3 independent biological experiments). (L and M) Flow cytometry shows unchanged CD45 surface expression in monocytes (Ly6G–Ly6C+) isolated from blood of MRP8-Cre;Cd45fl/fl mice relative to Cd45fl/fl control mice. Data represent MFI (n = 3 independent experiments). Data are shown as mean ± SEM and were analyzed by 1-way ANOVA with Tukey’s post hoc testing (F, H, K, M)or unpaired, 2-tailed t test (A, C). *P < 0.05; **P < 0.01; ****P < 0.0001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts